Govt Job for M.Pharm, M.Sc as Junior Research Fellow at NIAB

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India.

The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Walk-in interview for One position of JRF under DBT funded project entitled “Molecular platform for epidemiology, disease mapping and development of diagnostics for economically important diseases of ducks” of Dr. Madhuri Subbiah (non-NER PI) initially for a period of less than three months.

Post : Junior Research Fellow

Fellowship amount : Rs. 31,000 +24% HRA.

Eligibility : Post Graduate degree in professional courses (M.Pharm / M. Tech in Life Sciences / M. V. Sc. etc.) or Post Graduate Degree in Life Sciences (Biotechnology/Biochemistry/Microbiology) with NET qualification.

Desired Experience : Molecular Biology techniques. Candidates having prior experience in molecular techniques involving nucleic acid isolation, quantification, amplification and with cell culture experiences will be preferred

Upper Age limit : 30 years

Interested eligible candidates are advised to attend the online walk-in interview on 23-07-2021 from 02:00 pm to 05:00 pm.

Those interested are requested to kindly email a photograph and copies of documents in support of date of birth, educational qualifications, experience certificates etc. to madhuri@niab.org.in at least two days in advance of the above interview date. Online Interview Link will be sent to the candidates.

Related Posts

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

New Delhi:  Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…

Boehringer Ingelheim launches AI centre for pharma research in London

Bengaluru: German drugmaker Boehringer Ingelheim is launching a ​centre for artificial ​intelligence and machine learning in London, it said ​on Monday, as it seeks to expand its AI capabilities in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid